← Open Payments lookup

AMANDA PYBUS: Open Payments

NPI 1164869954 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,275 in 162 payments from 20 companies in 2025. Trend: 2023 $2,527 · 2024 $2,687 · 2025 $3,275

Food & beverage: $3,275
CompanyPaymentsAmount
GlaxoSmithKline, LLC.30$507
AstraZeneca Pharmaceuticals LP19$468
Boehringer Ingelheim Pharmaceuticals, Inc.15$330
GENZYME CORPORATION10$255
Insmed, Inc.12$240
Regeneron Healthcare Solutions, Inc.12$236
Takeda Pharmaceuticals U.S.A., Inc.12$232
Amgen Inc.12$195
United Therapeutics Corporation7$166
Verona Pharma, Inc.8$146

Products named: TEZSPIRE, DUPIXENT, TRELEGY ELLIPTA, Arikayce, NUCALA, OFEV, Tyvaso, Ohtuvayre.

Industry payments across AL — which companies pay providers there.